Parkinson's Disease Trial, Recruiting NCT06701955 Sponsor: University Hospital, Grenoble Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06701955
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged over 30 and up to 75 years old
  • People who have been diagnosed with idiopathic Parkinson's disease (the most common form of Parkinson's, not caused by another condition), according to recognised medical guidelines
  • People who experience motor fluctuations — periods where their Parkinson's symptoms change, such as times when medication seems to wear off — as reported by the person, a family member, or noticed by a doctor
  • People whose Parkinson's medications have remained unchanged for at least one month
  • People who speak and understand French
  • People who are able to give their informed consent to take part
  • People who are enrolled in the French social security system

Who may not be able to join:

  • People whose Parkinson's-like symptoms are caused by a condition other than idiopathic Parkinson's disease
  • People who have dementia, indicated by a score below 23 on a standard memory and thinking test called the MoCA
  • People who are not currently on any Parkinson's medication, or whose medication has been changed within the last month
  • People who fall into specific legally protected categories under French law, including pregnant women, women who have recently given birth, breastfeeding mothers, people detained by legal or administrative order, people receiving certain types of involuntary psychiatric care, people staying in a health or social care facility for reasons unrelated to research, minors, and people who are under a legal protection measure or unable to give consent
  • People who are currently participating in another interventional clinical study, or are within an exclusion period following one

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 4 76765791

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

validation of test-retest reliabililty

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov